What is the current Price Target for the Hookipa Pharma, Inc. stock?

The average Hookipa Pharma, Inc. target price is $4.50. This is 435.65% higher than the current stock price. The highest price target is 733.23%, the lowest is 138.07%. 2 Analysts have issued a price target Hookipa Pharma, Inc. 2026 .

How high will the Hookipa Pharma, Inc. stock rise?

No reliable answer can be given as to how high the Hookipa Pharma, Inc. stock will rise. The performance of stocks, including the Hookipa Pharma, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Hookipa Pharma, Inc. stock today?

The performance of Hookipa Pharma, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Hookipa Pharma, Inc. stock fall?

The decline in Hookipa Pharma, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Hookipa Pharma, Inc. Forecast, price target & analysts

$0.84

7.71% yesterday

Nasdaq, Apr 24, 10:00 pm CET

ISIN

US43906K1007

Symbol

HOOK

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Hookipa Pharma, Inc. Target price 2025 - Analyst rating & recommendation

Hookipa Pharma, Inc. Classifications & Recommendation:

Buy

50%

Hold

50%

Hookipa Pharma, Inc. Price Target

Target Price	$4.50
Price	$0.84
Potential	435.65% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Hookipa Pharma, Inc. 2026 . The average Hookipa Pharma, Inc. target price is $4.50. This is 435.65% register free of charge higher than the current stock price. The highest price target is $7.00 733.23% register free of charge , the lowest is $2.00 138.07% register free of charge .
	A rating was issued by 2 analysts: 1 Analysts recommend Hookipa Pharma, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Hookipa Pharma, Inc. stock has an average upside potential 2026 of 435.65% register free of charge . Most analysts recommend the Hookipa Pharma, Inc. stock at Buy or hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Million $	43.95	13.50
	118.33%	69.28%

1 Analyst has issued a sales forecast Hookipa Pharma, Inc. 2025 . The average Hookipa Pharma, Inc. sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$44.0m	118.33%
2025	$13.5m 69.28% Unlock
2026	$1.0m 92.59% Unlock
2027	$10.0m 900.00% Unlock
2028	$20.0m 100.00% Unlock
2029	$20.0m 0.00% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
EV/Sales		negative

Based on analysts' sales estimates for 2025, the Hookipa Pharma, Inc. stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	-0.65	65.61%
2025	-2.13 227.86% Unlock
2026	-28.77 1,250.01% Unlock
2027	-2.88 90.00% Unlock
2028	-1.44 50.00% Unlock
2029	-1.44 0.00% Unlock

Current	0.23	93.60%
2025	0.75 225.55% Unlock
2026	10.13 1,249.95% Unlock
2027	1.01 90.00% Unlock
2028	0.51 50.00% Unlock
2029	0.51 0.00% Unlock

Hookipa Pharma, Inc....

Current Hookipa Pharma, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 10 2025
RBC Capital	Locked ➜ Locked	Locked	Dec 20 2024
JMP Securities	Locked ➜ Locked	Locked	Nov 21 2024
RBC Capital	Locked ➜ Locked	Locked	Nov 15 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 10 2025
Locked RBC Capital: Locked ➜ Locked	Dec 20 2024
Locked JMP Securities: Locked ➜ Locked	Nov 21 2024
Locked RBC Capital: Locked ➜ Locked	Nov 15 2024

Discover more stocks with a high price target

Alibaba Group Holding Ltd 40.16%

Infineon 38.53%

Coinbase Global, Inc. 35.91%

Walt Disney 35.73%

Amazon.com 33.50%

Meta Platforms (Facebook) 33.34%

Tencent Holdings Ltd. 30.34%

Daimler Truck 30.06%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now